Gene Symbol: HIST2H2BD (Histone Cluster 2 H2B Family Member D)
UniProt ID: Q6DRA6
Chromosomal Location: 1q21.2
Protein Family: Histone H2B, core nucleosomal protein
| Property | Details |
|---|---|
| Amino Acid Length | 126 residues |
| Molecular Weight | ~14 kDa (theoretical) |
| Post-Translational Modifications | Predicted ubiquitylation, methylation, and acetylation sites based on H2B conservation |
HIST2H2BD belongs to the histone H2B family, which forms nucleosomes by pairing with H2A and wrapping DNA. Unlike canonical H2B, "putative" variants like HIST2H2BD are less characterized but hypothesized to regulate chromatin structure or gene expression in cell type-specific contexts .
| Feature | Canonical H2B | HIST2H2BD (Putative) |
|---|---|---|
| Expression | Ubiquitous | Tissue-specific (inferred) |
| Conservation | High across eukaryotes | Limited to primates |
| Functional Data | Well-studied | Predominantly computational |
Recombinant HIST2H2BD is synthesized in E. coli systems, mirroring methods for other human histones .
While HIST2H2BD itself is not directly linked to disease, mutations in H2B globular domains (e.g., E76K in H2BC18) disrupt nucleosome stability and promote oncogenic gene expression in cancers . This underscores the functional sensitivity of H2B structural residues.
Recombinant Human Putative Histone H2B type 2-D (HIST2H2BD): Background and Function
A core nucleosome component. Nucleosomes compact DNA into chromatin, restricting DNA accessibility for cellular machinery requiring DNA templates. Histones thus play a crucial role in transcriptional regulation, DNA repair, replication, and chromosomal stability. DNA accessibility is modulated through complex post-translational histone modifications, also known as the histone code, and nucleosome remodeling.
Initial characterization of recombinant HIST2H2BD should employ a multi-faceted approach. SDS-PAGE and Western blotting provide basic confirmation of protein identity, molecular weight, and purity. For deeper characterization, chromatin immunoprecipitation (ChIP) can assess genomic localization patterns. When designing experiments, follow structured protocols that include appropriate controls and multiple technical replicates to ensure data reliability .
The experimental design should include:
Qualitative observations (protein behavior during purification)
Quantitative measurements (protein concentration, purity percentage)
Statistical analysis including measures of central tendency and variation
For nucleosome incorporation studies, reconstitution assays using salt dialysis methods help determine how efficiently HIST2H2BD incorporates into chromatin compared to canonical H2B. Mass spectrometry provides the most comprehensive analysis of post-translational modifications and should be employed to establish the modification profile of your recombinant protein.
While specific HIST2H2BD data is limited, studies of H2B variants demonstrate that subtle sequence variations between variants can significantly impact nucleosome stability and dynamics. H2B is known to participate in important chromatin functions, particularly through its C-terminal ubiquitination, which influences transcription and RNA processing .
During transcription, RNA polymerase II acts as a scaffold for chromatin-modifying complexes, and H2B modifications regulate this process. Unlike H2A ubiquitination, H2B ubiquitination (uH2B) is evolutionarily conserved and enriched at transcribed regions, with abundance correlating with gene expression levels . The specific role of HIST2H2BD in this process requires direct investigation, focusing on how its sequence variations might affect these regulatory mechanisms.
Deubiquitination of histone H2B plays a critical regulatory role in gene expression. Enzymes like USP49 have been identified as H2B-specific deubiquitinases that do not affect other histones such as H2A . Studies show that USP49 depletion results in a dose-dependent increase in uH2B levels without affecting uH2A, indicating precise regulatory specificity .
Experimental evidence indicates that H2B deubiquitination regulates cotranscriptional pre-mRNA processing events. When designing experiments to investigate HIST2H2BD deubiquitination, researchers should:
Include both wild-type and catalytically inactive USP49 as controls
Measure changes in uH2B levels via Western blotting
Assess effects on pre-mRNA splicing through RNA-seq
Monitor U1A and U2B association with chromatin and nascent pre-mRNA
The research demonstrates that changes in H2B ubiquitination levels modulated by USP49 regulate spliceosome component association with chromatin, linking histone modifications directly to RNA processing mechanisms .
The macromolecular assembly state of histones dramatically affects their susceptibility to post-translational modifications. Research on protein arginine methyltransferases (PRMTs) demonstrates that the substrate context has a profound impact on histone arginine methylation activity .
For example, PRMT1 displays different methylation patterns depending on histone context:
Strongly methylates free H2A and H4 proteins
In H2A/H2B dimers, primarily methylates H2A
This context-dependent behavior occurs because the formation of higher-order histone complexes shields certain modification sites while exposing others. When designing experiments to study HIST2H2BD methylation, researchers must carefully consider which form of the protein (free, dimer, octamer, or nucleosome) to use, as results will vary dramatically between these contexts.
| Histone Context | PRMT1 Methylation Target | Accessibility of H2B Sites |
|---|---|---|
| Free histones | H2A and H4 | High |
| H2A/H2B dimer | Primarily H2A | Moderate |
| Histone octamer | Exclusively H4 | Low |
| Nucleosome | Restricted access | Very low |
This data demonstrates why experimental design must account for the macromolecular context when studying histone modifications .
When investigating HIST2H2BD ubiquitination, experimental design must address both technical challenges and biological complexity. A comprehensive experimental design should include the following components:
Clear problem statement defining the relationship between ubiquitination (independent variable) and the process being studied, such as transcription or splicing (dependent variable)
Hypothesis formulation that specifically predicts how changing ubiquitination levels will affect HIST2H2BD function
Controls including:
Other histones like H2A to verify modification specificity
Catalytically inactive enzyme mutants
Standard of comparison for ubiquitination levels
For data collection, both qualitative observations (changes in protein behavior) and quantitative measurements (ubiquitination levels) should be recorded throughout the experiment . Statistical analysis must include measures of central tendency (mean) and variation (standard deviation or range), with appropriate graphs to visualize trends .
Previous research provides a framework: studies on USP49 demonstrated that overexpression of wild-type USP49 reduced uH2B levels while catalytically inactive mutants had no effect, confirming specificity of the deubiquitination process .
Studies of histone interactions with PRMTs require specialized methodological approaches due to the context-dependent nature of these interactions. When designing experiments to analyze HIST2H2BD-PRMT interactions, researchers should:
Test multiple contexts: Compare free HIST2H2BD, H2A/H2B dimers, histone octamers, and nucleosomes in parallel
Include comprehensive controls:
Other histone types to confirm specificity
Multiple PRMT enzymes to identify enzyme-specific effects
Time-course analysis to capture dynamic interactions
Research has shown that PRMTs like PRMT1, PRMT3, and PRMT5 methylate various histone proteins with different specificities. PRMT1 asymmetrically dimethylates H4R3, correlating with transcriptional activation . PRMT5 can methylate H2A, H3, and H4, with H2AR3me2s and H4R3me2s modifications associated with gene repression .
Experimental approaches should incorporate both in vitro methylation assays using purified components and cellular studies to validate findings in a physiological context. Quantitative data must be collected using appropriate statistical approaches and should be presented with error measurements to account for experimental variation.
Contradictory results in histone modification studies often stem from differences in experimental context. When facing such contradictions, researchers should systematically evaluate:
Experimental materials and methods used:
Protein context (free protein vs. incorporated in chromatin structures)
Enzymatic conditions (concentrations, buffers, co-factors)
Detection methods (antibody specificity issues)
Qualification of observations:
Evidence from histone methylation studies illustrates this challenge: PRMT1 strongly methylates free H2A but loses this ability when H2A is incorporated into octamers . This demonstrates how molecular context dramatically affects modification patterns and can explain apparently contradictory results when comparing studies using different histone preparations.
Quantitative analysis of histone modifications requires rigorous statistical approaches tailored to the specific experimental design. Appropriate statistical measures include:
For comparing modification levels across conditions:
Data visualization should include:
Research on H2B deubiquitination by USP49 has revealed a critical connection between histone modifications and RNA processing. Studies show that USP49 depletion affects H2B ubiquitination levels and subsequently alters U1A and U2B association with chromatin and nascent pre-mRNA . This establishes a mechanistic link between histone modification states and splicing regulation.
Future HIST2H2BD research should investigate:
Specific exons or introns affected by HIST2H2BD modification states
Interactions between HIST2H2BD and spliceosome components
How HIST2H2BD variants might differ in their impact on RNA processing
Experimental approaches could combine ChIP-seq to map HIST2H2BD genomic locations with RNA-seq to identify splicing changes, creating a comprehensive picture of how this specific histone variant influences cotranscriptional processes.
When investigating HIST2H2BD in disease contexts, researchers should implement a systematic experimental design approach that includes:
Clear problem definition linking HIST2H2BD modifications to disease mechanisms
Hypothesis formulation with testable predictions about how HIST2H2BD variants or modifications contribute to pathogenesis
Appropriate controls including:
Healthy tissue/cell comparisons
Multiple disease stages
Treatment response studies
Quantitative data collection should measure:
HIST2H2BD modification levels in disease vs. normal tissues
Correlation with disease progression markers
Changes in response to therapeutic interventions
Statistical analysis must apply appropriate tests for significance while also reporting effect sizes to determine biological relevance . Recommendations for future experiments should specify improvements to the current experimental design and suggest practical applications of findings .